Summary
- Current Price
- As of today, TBPH price is $16.95, down -0.41% in the most recent trading session on
- Current Price All-Time High
- TBPH price is currently -60.98% below its historical high of $43.44 set on
- Market Cap
- TBPH current market cap is $873M, up +76.40% over the past 365 days
- PE Ratio
- TBPH current PE ratio is 8.36
- Revenue
- TBPH current annual revenue is $107.46M, up +66.92% year-over-year
- Next Earnings
- As of today, the next earnings release for TBPH has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Theravance Biopharma, Inc. |
| Ticker | NASDAQ: TBPH |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | theravance.com |
| Employees | 97 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $16.95 | |
| Price, 1D Change | -0.41% | |
| $873M | ||
| - | ||
| 8.36 | ||
| 0.89 | ||
| $107M | ||
| Revenue, 1Y Change | +66.92% | |
| $2.06 | ||
| EPS, 1Y Change | +278.00% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $2.06 | ||
| EPS Estimate | N/A | $4.40 |
| EPS Est. Change | N/A | +114.02% |
| $107.46M | ||
| Revenue Estimate | N/A | $92.75M |
| Revenue Est. Change | N/A | -13.69% |
| Current Price | $16.95 | |
| Price Target | - | $17.00 |
| Price Tgt. Change | - | +0.29% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.42 | -$1.16 | -172.86% | |
| $0.12 | $2.06 | +1,613.25% | |
| $4.40 | N/A | +114.02% | |
| $1.36 | N/A | -34.09% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $62.58M | $64.38M | +2.89% | |
| $111.33M | $107.46M | -3.47% | |
| $92.75M | N/A | -13.69% | |
| $87.40M | N/A | -18.68% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $16.95 | |
| $16.06 | ||
| SMA 200 vs Price | -5.27% | |
| $15.76 | ||
| SMA 50 vs Price | -7.00% | |
| 0.89 | ||
| $0.46 | ||
| 59.66 | ||
| 14.60% | ||
| 53.58% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $107.46M | ||
| $2.06 | ||
| $0.00 | ||
| 0.00% | ||
| -$3.60M | ||
| -3.35% | ||
| $105.90M | ||
| 98.54% | ||
| -$7.73M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.11 | ||
| 10.93 | ||
| 10.93 | ||
| - | ||
| 7 | ||
| 1.43 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 8.36 | ||
| 8.13 | ||
| 2.94 | ||
| -1,552.25 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $296.72M | ||
| $315.36M | ||
| $485.57M | ||
| $418.46M | ||
| $188.85M | ||
| $38.30M | ||
| $31.76M | ||
| $10.95M | ||
| $2.57M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $1.57M | ||
| $3.60M | ||
| $5.52M | ||
| $0.00 | ||
| $5.64M | ||
| $0.00 | ||
| $23.35M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $238.54M | ||
| -$105.28M | ||
| -$3.25M | ||
| $42.00K | ||
| $238.50M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| B. Riley Securities | → | |
| TD Cowen | → | |
| BTIG | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| B. Riley Securities | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Oppenheimer |
Analyst sentiment
Institutional ownership
Screeners with TBPH
FAQ
What is the ticker symbol for Theravance Biopharma, Inc.?
The ticker symbol for Theravance Biopharma, Inc. is NASDAQ:TBPH
Does Theravance Biopharma, Inc. pay dividends?
No, Theravance Biopharma, Inc. does not pay dividends
What sector is Theravance Biopharma, Inc. in?
Theravance Biopharma, Inc. is in the Healthcare sector
What industry is Theravance Biopharma, Inc. in?
Theravance Biopharma, Inc. is in the Biotechnology industry
What country is Theravance Biopharma, Inc. based in?
Theravance Biopharma, Inc. is headquartered in United States
When did Theravance Biopharma, Inc. go public?
Theravance Biopharma, Inc. initial public offering (IPO) was on May 16, 2014
Is Theravance Biopharma, Inc. in the S&P 500?
No, Theravance Biopharma, Inc. is not included in the S&P 500 index
Is Theravance Biopharma, Inc. in the NASDAQ 100?
No, Theravance Biopharma, Inc. is not included in the NASDAQ 100 index
Is Theravance Biopharma, Inc. in the Dow Jones?
No, Theravance Biopharma, Inc. is not included in the Dow Jones index
When was Theravance Biopharma, Inc. last earnings report?
Theravance Biopharma, Inc.'s most recent earnings report was on May 7, 2026
When does Theravance Biopharma, Inc. report earnings?
The date for Theravance Biopharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- TBPH Official Website www.theravance.com
- TBPH Profile on Yahoo Finance finance.yahoo.com/quote/TBPH
- TBPH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tbph